TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.77
+0.05 (0.87%)
Feb 21, 2025, 4:00 PM EST - Market closed
TriSalus Life Sciences Revenue
TriSalus Life Sciences had revenue of $7.35M in the quarter ending September 30, 2024, with 41.52% growth. This brings the company's revenue in the last twelve months to $26.89M, up 67.90% year-over-year. In the year 2023, TriSalus Life Sciences had annual revenue of $18.51M with 49.31% growth.
Revenue (ttm)
$26.89M
Revenue Growth
+67.90%
P/S Ratio
5.21
Revenue / Employee
$240,098
Employees
112
Market Cap
175.95M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 18.51M | 6.11M | 49.31% |
Dec 31, 2022 | 12.40M | 4.00M | 47.58% |
Dec 31, 2021 | 8.40M | 2.97M | 54.60% |
Dec 31, 2020 | 5.43M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTLSI News
- 18 days ago - TriSalus Life Sciences Announces Key Appointments to Board of Directors - Business Wire
- 19 days ago - TriSalus Life Sciences Announces Drawdown of $10 Million Tranche Under Credit Agreement with OrbiMed - Business Wire
- 4 weeks ago - TriSalus Life Sciences Announces Preliminary Q4 and Full Year Unaudited 2024 Financial Results and Conference Call - Business Wire
- 6 weeks ago - TriSalus Life Sciences® Announces Publication of Pre-Clinical Data Demonstrating Improved Delivery of Embospheres® to Liver Tumors using Pressure-Enabled Drug Delivery™ (PEDD™) via the TriNav® Infusion System - Business Wire
- 2 months ago - TriSalus Life Sciences: Continuing To Maintain Optimism As Costs Are Cut - Seeking Alpha
- 3 months ago - TriSalus Life Sciences, Inc. (TLSI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - TriSalus Reports Q3 2024 Financial Results and Provides Business Update - Business Wire
- 3 months ago - TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer - Business Wire